# A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

> clinical trial · VERIFIED · 2026-07-15

Status: RECRUITING · Sponsor: Astellas Pharma Global Development, Inc. · Condition: Pancreatic Ductal Adenocarcinoma

- Company: Astellas Pharma Global Development, Inc.
- Sector: Pancreatic Ductal Adenocarcinoma
- Primary source: https://clinicaltrials.gov/study/NCT07024615

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.